Targeting the β-catenin signaling for cancer therapy
- 1 October 2020
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 160, 104794
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81703757, 81874210, 81874319, 81803754)
- Science and Technology Commission of Shanghai Municipality (18401933500)
- Shanghai Municipal Education Commission (2019-01-07-00-10-E00072)
- China Postdoctoral Science Foundation (2018M642063)
This publication has 140 references indexed in Scilit:
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- The many faces and functions of β‐cateninThe EMBO Journal, 2012
- FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma TumorigenesisCancer Cell, 2011
- A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesisCell Research, 2011
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1αNature Chemical Biology, 2010
- Cross-regulation of signaling pathways: An example of nuclear hormone receptors and the canonical Wnt pathwayExperimental Cell Research, 2010
- Threonine 393 of β‐catenin regulates interaction with AxinJournal of Cellular Biochemistry, 2009
- Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem CellsCell, 2009
- Smad2 functions as a co-activator of canonical Wnt/β-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300Cellular Signalling, 2008
- Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt SignalingCell, 2008